Alanine aimnotranserase hepatitis foundation of new zealand hfzn 2015

A very specific topic!

The Alanine Aminotransferase (ALT) Hepatitis Foundation of New Zealand (HFZ) is a non-profit organization that aims to raise awareness and support for individuals affected by hepatitis B and C, particularly those with elevated ALT levels.

Here are some key points about the HFZ and its activities in 2015:

Mission: The HFZ's mission is to "improve the lives of people affected by hepatitis B and C by providing education, support, and advocacy."

Objectives: The organization's objectives include:

  1. Raising awareness about hepatitis B and C among the general public, healthcare professionals, and policymakers.
  2. Providing education and support to individuals affected by hepatitis B and C, including those with elevated ALT levels.
  3. Advocating for improved healthcare services and policies related to hepatitis B and C.

Activities in 2015: In 2015, the HFZ organized several events and activities to achieve its objectives, including:

  1. Hepatitis Awareness Week: The organization participated in Hepatitis Awareness Week, which took place from September 14 to 20, 2015. During this week, the HFZ organized various events, including a charity walk, a fundraising dinner, and a health fair.
  2. Education and support programs: The HFZ provided education and support programs for individuals affected by hepatitis B and C, including those with elevated ALT levels. These programs included workshops, support groups, and one-on-one counseling.
  3. Advocacy efforts: The organization advocated for improved healthcare services and policies related to hepatitis B and C. In 2015, the HFZ submitted a submission to the New Zealand Government's Ministry of Health on the need for improved hepatitis B and C testing and treatment services.

Impact: The HFZ's activities in 2015 helped to raise awareness about hepatitis B and C among the general public and healthcare professionals. The organization also provided education and support to individuals affected by these diseases, and advocated for improved healthcare services and policies.

Overall, the HFZ's work in 2015 contributed to a better understanding of hepatitis B and C, and helped to improve the lives of individuals affected by these diseases in New Zealand.